These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26783537)

  • 1. Postnatal Hematopoiesis and Gut Microbiota in NOD Mice Deviate from C57BL/6 Mice.
    Damlund DS; Metzdorff SB; Hasselby JP; Wiese M; Lundsager M; Nielsen DS; Buschard KS; Hansen AK; Frøkiær H
    J Diabetes Res; 2016; 2016():6321980. PubMed ID: 26783537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-life exposure to gut microbiota from disease-protected mice does not impact disease outcome in type 1 diabetes susceptible NOD mice.
    Mullaney JA; Stephens JE; Geeling BE; Hamilton-Williams EE
    Immunol Cell Biol; 2019 Jan; 97(1):97-103. PubMed ID: 30191611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
    Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
    ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gut Microbiome in the NOD Mouse.
    Peng J; Hu Y; Wong FS; Wen L
    Methods Mol Biol; 2016; 1433():169-77. PubMed ID: 27032947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.
    Tanca A; Palomba A; Fraumene C; Manghina V; Silverman M; Uzzau S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal acquisition of
    Kim YG; Sakamoto K; Seo SU; Pickard JM; Gillilland MG; Pudlo NA; Hoostal M; Li X; Wang TD; Feehley T; Stefka AT; Schmidt TM; Martens EC; Fukuda S; Inohara N; Nagler CR; Núñez G
    Science; 2017 Apr; 356(6335):315-319. PubMed ID: 28428425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic-associated Manipulation of the Gut Microbiota and Phenotypic Restoration in NOD Mice.
    Fahey JR; Lyons BL; Olekszak HL; Mourino AJ; Ratiu JJ; Racine JJ; Chapman HD; Serreze DV; Baker DL; Hendrix NK
    Comp Med; 2017 Aug; 67(4):335-343. PubMed ID: 28830580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial Enteral Nutrition Preserves Elements of Gut Barrier Function, Including Innate Immunity, Intestinal Alkaline Phosphatase (IAP) Level, and Intestinal Microbiota in Mice.
    Wan X; Bi J; Gao X; Tian F; Wang X; Li N; Li J
    Nutrients; 2015 Aug; 7(8):6294-312. PubMed ID: 26247961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ameliorating gut microenvironment through staphylococcal nuclease-mediated intestinal NETs degradation for prevention of type 1 diabetes in NOD mice.
    Liang Y; Wang X; He D; You Q; Zhang T; Dong W; Fei J; Xing Y; Wu J
    Life Sci; 2019 Mar; 221():301-310. PubMed ID: 30776371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier.
    Gouyer V; Dubuquoy L; Robbe-Masselot C; Neut C; Singer E; Plet S; Geboes K; Desreumaux P; Gottrand F; Desseyn JL
    Sci Rep; 2015 May; 5():9577. PubMed ID: 25974250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular matrix distribution and islet morphology in the early postnatal pancreas: anomalies in the non-obese diabetic mouse.
    Geutskens SB; Homo-Delarche F; Pleau JM; Durant S; Drexhage HA; Savino W
    Cell Tissue Res; 2004 Dec; 318(3):579-89. PubMed ID: 15480796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic treatment of pregnant non-obese diabetic mice leads to altered gut microbiota and intestinal immunological changes in the offspring.
    Tormo-Badia N; Håkansson Å; Vasudevan K; Molin G; Ahrné S; Cilio CM
    Scand J Immunol; 2014 Oct; 80(4):250-60. PubMed ID: 24965690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Muc2 mucin O-glycosylation is affected by microbiota and regulated by differential expression of glycosyltranferases.
    Arike L; Holmén-Larsson J; Hansson GC
    Glycobiology; 2017 Apr; 27(4):318-328. PubMed ID: 28122822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strain-specific helper T cell profile in the gut-associated lymphoid tissue.
    Stanisavljević S; Đedović N; Vujičić M; Saksida T; Jevtić B; Milovanović B; Momčilović M; Miljković Đ; Stojanović I
    Immunol Lett; 2017 Oct; 190():282-288. PubMed ID: 28851631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of delivery shapes gut colonization pattern and modulates regulatory immunity in mice.
    Hansen CH; Andersen LS; Krych L; Metzdorff SB; Hasselby JP; Skov S; Nielsen DS; Buschard K; Hansen LH; Hansen AK
    J Immunol; 2014 Aug; 193(3):1213-22. PubMed ID: 24951818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome analysis reveals regional and temporal differences in mucosal immune system development in the small intestine of neonatal calves.
    Liang G; Malmuthuge N; Bao H; Stothard P; Griebel PJ; Guan le L
    BMC Genomics; 2016 Aug; 17(1):602. PubMed ID: 27515123
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hänninen A; Toivonen R; Pöysti S; Belzer C; Plovier H; Ouwerkerk JP; Emani R; Cani PD; De Vos WM
    Gut; 2018 Aug; 67(8):1445-1453. PubMed ID: 29269438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.
    Candon S; Perez-Arroyo A; Marquet C; Valette F; Foray AP; Pelletier B; Milani C; Ventura M; Bach JF; Chatenoud L
    PLoS One; 2015; 10(5):e0125448. PubMed ID: 25970503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.
    Dolpady J; Sorini C; Di Pietro C; Cosorich I; Ferrarese R; Saita D; Clementi M; Canducci F; Falcone M
    J Diabetes Res; 2016; 2016():7569431. PubMed ID: 26779542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.